Cargando…

Scalable downstream method for the cyclic lipopetide jagaricin

Cyclic lipopeptides are substances with a high potential to act as antimicrobial agents. Jagaricin, produced by Janthinobacterium agaricidamnosum DSM 9628 and discovered in 2012, is a new member of this class with promising antifungal properties. However, further experiments to investigate future ap...

Descripción completa

Detalles Bibliográficos
Autores principales: Stein, Jakob, Schlosser, Nicolas, Bardl, Bettina, Peschel, Gundela, Meyer, Florian, Kloss, Florian, Rosenbaum, Miriam A., Regestein, Lars
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9731587/
https://www.ncbi.nlm.nih.gov/pubmed/36514532
http://dx.doi.org/10.1002/elsc.202100079
_version_ 1784845937234935808
author Stein, Jakob
Schlosser, Nicolas
Bardl, Bettina
Peschel, Gundela
Meyer, Florian
Kloss, Florian
Rosenbaum, Miriam A.
Regestein, Lars
author_facet Stein, Jakob
Schlosser, Nicolas
Bardl, Bettina
Peschel, Gundela
Meyer, Florian
Kloss, Florian
Rosenbaum, Miriam A.
Regestein, Lars
author_sort Stein, Jakob
collection PubMed
description Cyclic lipopeptides are substances with a high potential to act as antimicrobial agents. Jagaricin, produced by Janthinobacterium agaricidamnosum DSM 9628 and discovered in 2012, is a new member of this class with promising antifungal properties. However, further experiments to investigate future applications and/or conduct chemical derivatization to change properties and toxicity are impossible due to the limited access to jagaricin. Besides a high jagaricin concentration at the end of the fermentation process, a suitable downstream process is essential to generate appropriate amounts with the desired purity. In contrast to other amphiphilic molecules, jagaricin cannot be separated by foam fractionation since it is mainly attached to the surface of the microbial biomass. This technical report presents an overall process chain consisting of 11 individual steps to generate jagaricin in gram scale with a purity of over 95%.
format Online
Article
Text
id pubmed-9731587
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-97315872022-12-12 Scalable downstream method for the cyclic lipopetide jagaricin Stein, Jakob Schlosser, Nicolas Bardl, Bettina Peschel, Gundela Meyer, Florian Kloss, Florian Rosenbaum, Miriam A. Regestein, Lars Eng Life Sci Technical Reports Cyclic lipopeptides are substances with a high potential to act as antimicrobial agents. Jagaricin, produced by Janthinobacterium agaricidamnosum DSM 9628 and discovered in 2012, is a new member of this class with promising antifungal properties. However, further experiments to investigate future applications and/or conduct chemical derivatization to change properties and toxicity are impossible due to the limited access to jagaricin. Besides a high jagaricin concentration at the end of the fermentation process, a suitable downstream process is essential to generate appropriate amounts with the desired purity. In contrast to other amphiphilic molecules, jagaricin cannot be separated by foam fractionation since it is mainly attached to the surface of the microbial biomass. This technical report presents an overall process chain consisting of 11 individual steps to generate jagaricin in gram scale with a purity of over 95%. John Wiley and Sons Inc. 2021-10-27 /pmc/articles/PMC9731587/ /pubmed/36514532 http://dx.doi.org/10.1002/elsc.202100079 Text en © 2021 The Authors. Engineering in Life Sciences published by Wiley‐VCH GmbH. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Technical Reports
Stein, Jakob
Schlosser, Nicolas
Bardl, Bettina
Peschel, Gundela
Meyer, Florian
Kloss, Florian
Rosenbaum, Miriam A.
Regestein, Lars
Scalable downstream method for the cyclic lipopetide jagaricin
title Scalable downstream method for the cyclic lipopetide jagaricin
title_full Scalable downstream method for the cyclic lipopetide jagaricin
title_fullStr Scalable downstream method for the cyclic lipopetide jagaricin
title_full_unstemmed Scalable downstream method for the cyclic lipopetide jagaricin
title_short Scalable downstream method for the cyclic lipopetide jagaricin
title_sort scalable downstream method for the cyclic lipopetide jagaricin
topic Technical Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9731587/
https://www.ncbi.nlm.nih.gov/pubmed/36514532
http://dx.doi.org/10.1002/elsc.202100079
work_keys_str_mv AT steinjakob scalabledownstreammethodforthecycliclipopetidejagaricin
AT schlossernicolas scalabledownstreammethodforthecycliclipopetidejagaricin
AT bardlbettina scalabledownstreammethodforthecycliclipopetidejagaricin
AT peschelgundela scalabledownstreammethodforthecycliclipopetidejagaricin
AT meyerflorian scalabledownstreammethodforthecycliclipopetidejagaricin
AT klossflorian scalabledownstreammethodforthecycliclipopetidejagaricin
AT rosenbaummiriama scalabledownstreammethodforthecycliclipopetidejagaricin
AT regesteinlars scalabledownstreammethodforthecycliclipopetidejagaricin